-The Telegraph New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme. The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said....

-Frontline Childhood TB has been neglected for decades, but in the past few years the WHO has begun to realise its real impact in terms of incidence, prevalence and mortality. THE number of annual new tuberculosis (TB) cases in India has been nearly 2.2 million for the past couple of years. Many of these infected people would have been in contact with children aged under five years before being diagnosed and,...

-The United Nations The United Nations health agency today released new treatment guidelines for the almost 20 million children under the age of five worldwide who have severe acute malnutrition, including options for allowing them to recover at home, as well as treating those with HIV. "The guidelines are critical because many national health plans currently overlook children with severe acute malnutrition. This can be fatal. If these children don't get the...

-The World Bank   Policy Interventions Can Turn the Tide, Says World Bank Report WASHINGTON: A new World Bank report warns that risky behaviors -smoking, using illicit drugs, alcohol abuse, unhealthy diets, and unsafe sex- are increasing globally and pose a growing threat to the health of individuals, particularly in developing countries. The report looks at how individual choices that lead to these behaviors are formed and reviews the effectiveness of interventions...

-The Hindu Unless a deeper, institutional change is ushered in to break the nexus between drug companies and the regulatory regime, Indians consuming drugs may be exposing themselves to serious risks Even before I walked into the Mayflower Hotel in the heart of Washington on a crisp autumn afternoon to meet Dinesh Thakur, whistle-blower and former director of India-based pharmaceutical giant Ranbaxy, I had a hunch that this conversation would spark some...